Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 17,801–17,820 of 18,765 recalls

FDA Recall Terminated Historical recordClass II

Nandrolone Decanoate Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MIC with B6 and B12, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin PF, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydroxyprogesterone CAPR.(G.S.), compounded by Pallimed Solutions Pharmacy, Woburn MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HCG Chorionic Gonadotropin, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gentamicin Sulfate Irrigation, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

DMSO Aqueous Irrigation 50%, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dexamethasone PF, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diazepam Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cyclosporine Ophthalmic, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cidofovir Opthalmic Solution, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Buprenorphine HCl Veterinary Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BiMix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Bacteriostatic Water for Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atropine Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprostadil IN NS Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Acetylcysteine Ophthalmic Solution, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Zolpidem Tartrate Tablets 5 mg, 10 tablets per blister, 10 blisters per carton, 100 cartons per box, Rx Only, Manufactured for Wockhardt USA LLC., Parsippany, NJ 07054 by Wockhardt Limited, Mumbai, India, NDC 68084-225-01

by American Health Packaging

Reason
Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose blisters to be packed with more than one tablet.
Published
August 14, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

by Actavis Inc

Reason
Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.
Published
August 14, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 day regimen per unit carton, 3 Unit Cartons x 91 tablets per box, Rx only, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5584-36

by Sandoz Incorporated

Reason
Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card
Published
August 14, 2013
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.